1. Pharmacotherapy of Mood Disorders and Treatment Discontinuation

   • Malcolm Lader

   Leading Article 14 September 2012 Pages: 1657 - 1663

   

2. Antileukotrienes as Adjunctive Therapy in Acute Asthma

   • Lieske M. E. Kuitert
   • Danie Watson

   Leading Article 14 September 2012 Pages: 1665 - 1670

   

3. Pathophysiology and Management of Diabetic Gastropathy

   • Paul Kuo
   • Christopher K. Rayner
   • Michael Horowitz

   Therapy In Practice 14 September 2012 Pages: 1671 - 1687

   

4. Current Management of Mantle Cell Lymphoma

   • Oliver Weigert
   • Michael Unterhalt
   • Martin Dreyling

   Review Article 14 September 2012 Pages: 1689 - 1702

   

5. Infliximab Therapy in Children and Adolescents with Inflammatory Bowel Disease

   • Gabor Veres
   • Robert N. Baldassano
   • Petar Mamula

   Review Article 14 September 2012 Pages: 1703 - 1723

   

6. Rasagiline

   • Vicki Oldfield
   • Gillian M. Keating
   • Caroline M. Perry

   Adis Drug Evaluation 14 September 2012 Pages: 1725 - 1747

   

7. Drospirenone/Ethinylestradiol 3mg/20µg (24/4 Day Regimen)

   • Caroline Fenton
   • Keri Wellington
   • Dean M. Robinson

   Adis Drug Evaluation 14 September 2012 Pages: 1749 - 1765

   

8. Aliskiren

   • James E. Frampton
   • Monique P. Curran

   Adis Drug Evaluation 14 September 2012 Pages: 1767 - 1792

   

9. Bevacizumab

   • Lesley J. Scott

   Adis Drug Profile 14 September 2012 Pages: 1793 - 1799

   

10. Bevacizumab in First-Line Treatment of Metastatic Breast Cancer

    • David Miles

    Adis Drug Profile 14 September 2012 Pages: 1800 - 1800

11. Bevacizumab in First-Line Treatment of Metastatic Breast Cancer

    • Xavier Pivot

    Adis Drug Profile 14 September 2012 Pages: 1800 - 1801